| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MARROW TRANSPLANT- HEMATOPOIETIC CELL TRANSPLANT FOR GENETIC DISEASES AND ACQUIRED ANEMIAS, ALLOGENEICPayerPolicy · BCBSM-2022265 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | (PEANUT IMMUNOTHERAPY TRANSDERMAL PATCH) VIASKIN PEANUT (J3490) (retired as of 10/06/2022)PayerPolicy · BCBSM-2138352 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR LYNCH SYNDROME AND OTHER INHERITED COLON CANCER SYNDROMES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198825 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | REDUCTION MAMMAPLASTY (BREAST REDUCTION) FOR BREAST-RELATED SYMPTOMS (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210524-CBD8F74084 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RADIOFREQUENCY ABLATION OF BASIVERTEBRAL NERVE FOR LOW BACK PAIN (I.E., INTRACEPT) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195912 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BCBSM ONLY: INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA) STREPTOCOCCUS GROUP APayerPolicy · BCBSM-2051906 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BRACHYTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER USING PERMANENTLY IMPLANTED SEEDS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2191558 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MARROW TRANSPLANT - HEMATOPOIETIC CELL TRANSPLANTATION FOR EPITHELIAL OVARIAN CANCER - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195786 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC AND LABORATORY TESTING FOR USE OF FLUOROPYRIMIDINES (E.G., 5-FLUOROURACIL AND CAPECITABINE) IN PATIENTS WITH CANCERPayerPolicy · BCBSM-2019297 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TELEMONITORING - REMOTE PATIENT MONITORING AND REMOTE THERAPEUTIC MONITORING (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210526-847A14B74F | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IRREVERSIBLE ELECTROPORATION OF TUMORS (E.G. NANOKNIFE) LOCATED IN THE LIVER, PANCREAS, KIDNEY, LUNG OR PROSTATEPayerPolicy · BCBSM-2208006 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | EYE MOVEMENT DESENSITIZATION AND REPROCESSING FOR POST-TRAUMATIC STRESS DISORDER (PTSD) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194860 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR FLT3, NPM1, CEBPA, IDH1 AND IDH2 VARIANTS IN ACUTE MYELOID LEUKEMIAPayerPolicy · BCBSM-2111323 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IRREVERSIBLE ELECTROPORATION OF TUMORS LOCATED IN THE LIVER, PANCREAS, KIDNEY, LUNG OR PROSTATE - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2210408 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | REVCOVI ( ELAPEGADEMASE-LVLR )ENZYME REPLACEMENT THERAPY (J3490) retired as of 10/8/2020PayerPolicy · BCBSM-2131964 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SKIN ADVANCED GLYCATION END PRODUCTS (AGE) MEASUREMENT BY MULTI-WAVELENGTH FLUORESCENT SPECTROSCOPYPayerPolicy · BCBSM-2014342 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENZYME REPLACEMENT THERAPY - SEBELIPASE ALFA: KANUMA (J2840) retired as of 10/8/2020PayerPolicy · BCBSM-2059568 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ULTRASONOGRAPHIC MEASUREMENT OF CAROTID INTIMA-MEDIA THICKNESS AS AN ASSESSMENT OF SUBCLINICAL ATHEROSCLEROSIS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197016 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MICROPROCESSOR-CONTROLLED & POWER PROSTHESES AND ORTHOSES FOR THE LOWER LIMB (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210514-FC0BFFFF36 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) (INSULIN PUMPS) AND TRANSDERMAL INSULIN DELIVERY SYSTEMSPayerPolicy · BCBSM-80190 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SCREENING FOR LUNG CANCER USING COMPUTED TOMOGRAPHY SCANNING OR CHEST RADIOGRAPHS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2196228 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MARROW TRANSPLANT - HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES AND MYELOPROLIFERATIVE NEOPLASMS, ALLOGENEICPayerPolicy · BCBSM-2031570 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | POSTSURGICAL HOME USE OF LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198283 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MAGNETIC ESOPHAGEAL SPHINCTER AUGMENTATION TO TREAT GASTROESOPHAGEAL REFLUX DISEASE (GERD) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193021 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRANSCRANIAL MAGNETIC STIMULATION AS A TREATMENT OF DEPRESSION AND OTHER PSYCHIATRIC/NEUROLOGIC DISORDERS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197269 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENZYME REPLACEMENT THERAPY - VELAGLUCERASE ALFA: VIMIZIM (J1322) RETIRED AS OF 10/8/2020PayerPolicy · BCBSM-2050196 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | VPRIV (VELAGLUCERASE ALFA) ENZYME REPLACEMENT THERAPY (J3385) retired as of 10/8/2020PayerPolicy · BCBSM-2132064 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY-MODULATED RADIATION THERAPY (IMRT) AND IMAGE-GUIDED RADIATION THERAPY (IGRT) OF THE PROSTATEPayerPolicy · BCBSM-2047383 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CORNEAL LIQUID BANDAGE LENS FOR CORNEAL EPITHELIAL DEFECTS/SCLERAL LENSES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195973 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SPINAL SURGERY: PERCUTANEOUS DISC DECOMPRESSION USING LASER ENERGY OR RADIOFREQUENCY COBLATION (NUCLEOPLASTY)PayerPolicy · BCBSM-82668 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - BCR-ABL1 TESTING IN CHRONIC MYELOGENOUS LEUKEMIA AND ACUTE LYMPHOBLASTIC LEUKEMIAPayerPolicy · BCBSM-2067646 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - DINUTUXIMAB: UNITUXIN (J9999) (J3490) (J3590) (C9399) (RETIRED AS OF 02/02/2023)PayerPolicy · BCBSM-2087318 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BCN ONLY - AUGMENTATIVE AND ALTERNATIVE COMMUNICATION DEVICES: SPEECH GENERATING DEVICES AND COMMUNICATION BOARDSPayerPolicy · BCBSM-2022402 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TELEMONITORING- REMOTE PATIENT MONITORING AND REMOTE THERAPEUTIC MONITORING (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209365-49658463AA | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAOPERATIVE NEUROPHYSIOLOGIC MONITORING (SENSORY-EVOKED POTENTIALS, MOTOR-EVOKED POTENTIALS, EEG MONITORING)PayerPolicy · BCBSM-2026111-A8362DF418 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENE EXPRESSION PROFILE ANALYSIS FOR RISK STRATIFICATION FOR PROSTATE CANCER MANAGEMENT - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198276 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING- MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES (FNA) OF THE THYROID - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198887 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PERONEAL NERVE STIMULATION (I.E, TOMAC) FOR TREATMENT OF RESTLESS LEGS SYNDROME - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2210407 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY-MODULATED RADIATION THERAPY (IMRT): CANCER OF THE HEAD AND NECK OR THYROID - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193814-F30E42890B | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MEASUREMENT OF SERUM AND ANTI-DRUG ANTIBODY LEVELS FOR SELECTED BIOLOGIC AGENTS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2192864 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LEFT ATRIAL PRESSURE MONITORING DEVICES FOR HEART FAILURE IN THE AMBULATORY CARE AND OUTPATIENT SETTINGPayerPolicy · BCBSM-2020358 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | COMPUTER-AIDED EVALUATION AS AN ADJUNCT TO MAGNETIC RESONANCE IMAGING FOR PROSTATE CANCER - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2201628 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | REFRACTIVE KERATOPLASTIES, PHOTOTHERAPEUTIC KERATECTOMY AND IMPLANTATION OF INTRASTROMAL CORNEAL RING SEGMENTS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198286 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD), INCLUDING SUBCUTANEOUS ICDS AND SUBSTERNAL ICDS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2196215 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LAPAROSCOPIC, PERCUTANEOUS, AND TRANSCERVICAL TECHNIQUES FOR UTERINE FIBROID MYOLYSIS (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210521-DAAB072081 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | DRUG COATED BALLOON FOR URETHRAL STRICTURES (I.E., OPTILUME URETHRAL DRUG COATED BALLOON)PayerPolicy · BCBSM-2199534 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BCBSM ONLY: Continuing Coverage of CPAP Machines and Supplies for the Treatment of Obstructive Sleep ApneaPayerPolicy · BCBSM-2018273 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | HEMOGLOBIN A1C TESTING DEVICE FOR HOME USE OR FOR USE AS A POINT OF CARE DEVICEPayerPolicy · BCBSM-106023 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | EXHALED NITRIC OXIDE AND EXHALED BREATH CONDENSATE IN THE DIAGNOSIS AND MANAGEMENT OF RESPIRATORY DISORDERSPayerPolicy · BCBSM-87127 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC CANCER SUSCEPTIBILITY PANELS USING NEXT GENERATION SEQUENCING - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198909 | New policy |
|---|